Thalidomide and dexamethasone in newly diagnosed multiple myeloma.

被引：0
|
作者：
McHugh, Johnny [1 ]
O'Ceallaigh, Cathal [1 ]
Keane, Colm [1 ]
Otridge, Brian W. [1 ]
O'Gorman, Peter [1 ]
机构：
[1] Mater Misericordiae Univ Hosp, Dept Haematol, Dublin, Ireland
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5120
引用
收藏
页码：370B / 370B
页数：1
相关论文
共 50 条
  • [31] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
    Zheng, Weiyan
    Wei, Guoqing
    Ye, Xiujin
    He, Jingsong
    Li, Li
    Wu, Wenjun
    Shi, Jimin
    Zhang, Jie
    Huang, Weijia
    Xie, Wanzhuo
    Luo, Yi
    Xue, Xingkui
    Lin, Maofang
    Huang, He
    Cai, Zhen
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1615 - 1618
  • [32] Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients.
    Chavez, Jule Franve Vasquez
    Mendoza, Rossana Esther Ruiz
    Llerena, Karina Mayra Aliaga
    Valencia, Fernando
    Enriquez, Daniel
    Palacios, Victor
    Casanova, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] An analysis of 1027 newly diagnosed cases of multiple myeloma.
    Kyle, RA
    Greipp, PR
    Witzig, TE
    Lust, JA
    Lacy, MQ
    Dispenzieri, A
    Fonseca, R
    Rajkumar, SV
    Offord, JR
    Therneau, TM
    BLOOD, 1999, 94 (10) : 537A - 537A
  • [34] Correlation of bone marrow angiogenesis and response to thalidomide dexamethasone in multiple myeloma.
    Kumar, S.
    Greipp, P. R.
    Haug, J. L.
    Gertz, M. A.
    Blood, E.
    Rajkumar, S. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 451S - 451S
  • [35] Primary therapy with thalidomide and dexamethasone in preparation to autologous transplantation for multiple myeloma.
    Cavo, M
    Zamagni, E
    Tosi, P
    Cellini, C
    de Vivo, A
    Cangini, D
    Tonelli, M
    Testoni, N
    Grafone, T
    Tacchetti, P
    Soverini, S
    Terragna, C
    Tura, S
    Baccarani, M
    BLOOD, 2003, 102 (11) : 448A - 448A
  • [36] Thalidomide in IgA multiple myeloma.
    Lim, SH
    Maclean, R
    BLOOD, 1998, 92 (10) : 279B - 279B
  • [37] A multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as initial therapy for newly diagnosed multiple myeloma.
    Rajkumar, S. V.
    Hussein, M.
    Catalano, J.
    Jedrzejcak, W.
    Sirkovich, S.
    Olesnyckyj, M.
    Yu, Z.
    Knight, R.
    Zeldis, J. B.
    Blade, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 426S - 426S
  • [38] Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
    Gay, Francesca
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, P. Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen J.
    Roy, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert A.
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    BLOOD, 2010, 115 (07) : 1343 - 1350
  • [39] Thromboprophylaxis with aspirin for newly diagnosed multiple myeloma treated with thalidomide plus dexamethasone: A preliminary report.
    Jimenez, Victor H.
    Dominguez, Virginia
    Reynoso, Eduardo
    Lopez, Indira
    BLOOD, 2006, 108 (11) : 362B - 362B
  • [40] Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma
    Sonneveld, Pieter
    Asselbergs, Emilie
    Zweegman, Sonja
    van der Holt, Bronno
    Kersten, Marie Jose
    Vellenga, Edo
    van Marwijk-Kooy, Marinus
    Broyl, Annemiek
    de Weerdt, Okke
    Lonergan, Sarah
    Palumbo, Antonio
    Lokhorstl, Henk
    BLOOD, 2015, 125 (03) : 449 - 456
12345